784 related articles for article (PubMed ID: 9106657)
21. Cytoplasmic displacement of cyclin E-cdk2 inhibitors p21Cip1 and p27Kip1 in anchorage-independent cells.
Orend G; Hunter T; Ruoslahti E
Oncogene; 1998 May; 16(20):2575-83. PubMed ID: 9632134
[TBL] [Abstract][Full Text] [Related]
22. p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21.
Toyoshima H; Hunter T
Cell; 1994 Jul; 78(1):67-74. PubMed ID: 8033213
[TBL] [Abstract][Full Text] [Related]
23. Lovastatin mediated G1 arrest in normal and tumor breast cells is through inhibition of CDK2 activity and redistribution of p21 and p27, independent of p53.
Rao S; Lowe M; Herliczek TW; Keyomarsi K
Oncogene; 1998 Nov; 17(18):2393-402. PubMed ID: 9811471
[TBL] [Abstract][Full Text] [Related]
24. Regulation of G(1) cyclin-dependent kinases in the liver: role of nuclear localization and p27 sequestration.
Albrecht JH; Rieland BM; Nelsen CJ; Ahonen CL
Am J Physiol; 1999 Dec; 277(6):G1207-16. PubMed ID: 10600818
[TBL] [Abstract][Full Text] [Related]
25. Estrogen-induced activation of Cdk4 and Cdk2 during G1-S phase progression is accompanied by increased cyclin D1 expression and decreased cyclin-dependent kinase inhibitor association with cyclin E-Cdk2.
Prall OW; Sarcevic B; Musgrove EA; Watts CK; Sutherland RL
J Biol Chem; 1997 Apr; 272(16):10882-94. PubMed ID: 9099745
[TBL] [Abstract][Full Text] [Related]
26. Role of p27(Kip1) in human intestinal cell differentiation.
Deschênes C; Vézina A; Beaulieu JF; Rivard N
Gastroenterology; 2001 Feb; 120(2):423-38. PubMed ID: 11159883
[TBL] [Abstract][Full Text] [Related]
27. Differential effects of the cyclin-dependent kinase inhibitors p27(Kip1), p21(Cip1), and p16(Ink4) on vascular smooth muscle cell proliferation.
Tanner FC; Boehm M; Akyürek LM; San H; Yang ZY; Tashiro J; Nabel GJ; Nabel EG
Circulation; 2000 May; 101(17):2022-5. PubMed ID: 10790340
[TBL] [Abstract][Full Text] [Related]
28. Transforming growth factor beta stabilizes p15INK4B protein, increases p15INK4B-cdk4 complexes, and inhibits cyclin D1-cdk4 association in human mammary epithelial cells.
Sandhu C; Garbe J; Bhattacharya N; Daksis J; Pan CH; Yaswen P; Koh J; Slingerland JM; Stampfer MR
Mol Cell Biol; 1997 May; 17(5):2458-67. PubMed ID: 9111314
[TBL] [Abstract][Full Text] [Related]
29. Interaction of retinoblastoma protein and D cyclins during cell-growth inhibition by hexamethylenebisacetamide in TM2H mouse epithelial cells.
Said TK; Medina D
Mol Carcinog; 1998 Jun; 22(2):128-43. PubMed ID: 9655257
[TBL] [Abstract][Full Text] [Related]
30. [Molecular mechanisms controlling the cell cycle: fundamental aspects and implications for oncology].
Viallard JF; Lacombe F; Belloc F; Pellegrin JL; Reiffers J
Cancer Radiother; 2001 Apr; 5(2):109-29. PubMed ID: 11355576
[TBL] [Abstract][Full Text] [Related]
31. Cooperation of p27(Kip1) and p18(INK4c) in progestin-mediated cell cycle arrest in T-47D breast cancer cells.
Swarbrick A; Lee CS; Sutherland RL; Musgrove EA
Mol Cell Biol; 2000 Apr; 20(7):2581-91. PubMed ID: 10713180
[TBL] [Abstract][Full Text] [Related]
32. Regulation and role of p21 and p27 cyclin-dependent kinase inhibitors during hepatocyte differentiation and growth.
Ilyin GP; Glaise D; Gilot D; Baffet G; Guguen-Guillouzo C
Am J Physiol Gastrointest Liver Physiol; 2003 Jul; 285(1):G115-27. PubMed ID: 12646420
[TBL] [Abstract][Full Text] [Related]
33. Cyclin D- and E-dependent kinases and the p57(KIP2) inhibitor: cooperative interactions in vivo.
Gómez Lahoz E; Liegeois NJ; Zhang P; Engelman JA; Horner J; Silverman A; Burde R; Roussel MF; Sherr CJ; Elledge SJ; DePinho RA
Mol Cell Biol; 1999 Jan; 19(1):353-63. PubMed ID: 9858559
[TBL] [Abstract][Full Text] [Related]
34. The cyclin-dependent kinase inhibitor p21WAF1/Cip1 is an antiestrogen-regulated inhibitor of Cdk4 in human breast cancer cells.
Skildum AJ; Mukherjee S; Conrad SE
J Biol Chem; 2002 Feb; 277(7):5145-52. PubMed ID: 11741909
[TBL] [Abstract][Full Text] [Related]
35. The p21(Cip1) and p27(Kip1) CDK 'inhibitors' are essential activators of cyclin D-dependent kinases in murine fibroblasts.
Cheng M; Olivier P; Diehl JA; Fero M; Roussel MF; Roberts JM; Sherr CJ
EMBO J; 1999 Mar; 18(6):1571-83. PubMed ID: 10075928
[TBL] [Abstract][Full Text] [Related]
36. Cloning of p57KIP2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution.
Lee MH; Reynisdóttir I; Massagué J
Genes Dev; 1995 Mar; 9(6):639-49. PubMed ID: 7729683
[TBL] [Abstract][Full Text] [Related]
37. Cyclin E/Cdk2 activity is controlled by different mechanisms in the G0 and G1 phases of the cell cycle.
Bresnahan WA; Boldogh I; Ma T; Albrecht T; Thompson EA
Cell Growth Differ; 1996 Oct; 7(10):1283-90. PubMed ID: 8891332
[TBL] [Abstract][Full Text] [Related]
38. Redistribution of the CDK inhibitor p27 between different cyclin.CDK complexes in the mouse fibroblast cell cycle and in cells arrested with lovastatin or ultraviolet irradiation.
Poon RY; Toyoshima H; Hunter T
Mol Biol Cell; 1995 Sep; 6(9):1197-213. PubMed ID: 8534916
[TBL] [Abstract][Full Text] [Related]
39. Cyclic AMP-dependent phosphorylation of cyclin D3-bound CDK4 determines the passage through the cell cycle restriction point in thyroid epithelial cells.
Paternot S; Coulonval K; Dumont JE; Roger PP
J Biol Chem; 2003 Jul; 278(29):26533-40. PubMed ID: 12730225
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of cyclin-dependent kinases 2 and 4 activities as well as induction of Cdk inhibitors p21 and p27 during growth arrest of human breast carcinoma cells by (-)-epigallocatechin-3-gallate.
Liang YC; Lin-Shiau SY; Chen CF; Lin JK
J Cell Biochem; 1999 Oct; 75(1):1-12. PubMed ID: 10462699
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
